SciELO - Scientific Electronic Library Online

 
vol.48 issue2Characterization of drug consumption behaviors in university students of Costa RicaCefepime encephalopathy in a kidney patient: an adverse reaction to the drug author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Ciencias Químico - Farmacéuticas

Print version ISSN 0034-7418On-line version ISSN 1909-6356

Abstract

ARANDA, Mónica  and  ROSASCO, María Ana. The pharmacy of generic drugs. Rev. colomb. cienc. quim. farm. [online]. 2019, vol.48, n.2, pp.357-371. ISSN 0034-7418.  https://doi.org/10.15446/rcciquifa.v48n2.82714.

Generic medicines give the chance to improve access to medicaments that the population needs, and the possibility of making public and private health programs more sustainable. Information and scientific evidence on this type of medicines has been selected in such a way that the readers - doctors, financiers, public and private organizations - can shape their own opinion and help take the most effective and efficient decisions. The relationship between the prices of these products and the protection of intellectual property through patents for medicines is a center of conflicts between the Pharmaceutical Industry and health systems. In the United States, the Hatch-Waxman Act has played a very important role in stimulating the development of generic drugs. By his side, the European Union (EU) has developed, through the European Medicines Agency (EMA), a homogenization in terms of authorization of medicines and exclusivity of data.

Keywords : Generics drugs; equivalence; bioequivalence; interchangeability; patents.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )